EIA (Coggins Test) at a Glance
EIA Transmission Routes
Comparison
| Disease Form | Signs | Duration | Outcome |
|---|---|---|---|
| Acute | High fever, anemia, edema | Days to weeks | Survival possible but chronic |
| Chronic | Recurrent fever, weight loss, edema | Months to years | Wasting syndrome |
| Subclinical | No visible signs | Permanent | Healthy-looking carrier |
| Peracute | Sudden death | Hours to days | Usually fatal |
EIA Management Flow
EIA/Coggins Management Checklist
| Annual Coggins test for all horses (required for travel) | |
| Use separate needles for every horse | |
| Implement fly control (traps, sprays, manure management) | |
| Report positive cases to state veterinarian immediately | |
| Permanently identify positive horses (brand, microchip) | |
| Quarantine EIA-positive horses 200 yards from others | |
| Do not breed EIA-positive mares | |
| Euthanasia may be required by state law for positive cases |
Equine Infectious Anemia (EIA) is a viral disease caused by a lentivirus (retrovirus family) transmitted by large biting insects (horseflies, deerflies) or contaminated needles. There is no treatment and no vaccine. Infected horses become lifelong virus carriers. In the United States, a negative Coggins test (AGID) or ELISA is required by law for interstate transport, sale, and entry to competitions. Horses that test positive must be euthanized or permanently quarantined 200 yards from other horses for life.
| Test Type | Detection Method | Legal Role |
|---|---|---|
| AGID (Coggins test) | Agar gel immunodiffusion — detects EIA antibodies | Gold standard; required for interstate transport |
| ELISA | High-volume screening; positive confirmed by AGID | Used for large-scale screening; same legal weight as AGID |
| Positive result | Antibodies present = lifelong infected carrier | Euthanasia or permanent 200-yd quarantine from other horses |
| Negative result | No EIA antibodies detected | Valid 12 months for interstate travel and most competitions |
What EIA does to the infected horse
EIA causes periodic febrile episodes (fever 104-108 degrees F), anemia from immune-mediated destruction of red blood cells, thrombocytopenia (low platelets, causing bruising and bleeding tendency), jaundice, ventral edema, and profound weakness. The acute form can be fatal within 2-3 weeks. Chronic carriers may appear healthy between episodes, showing only mild clinical signs for months to years before declining. Inapparent carriers show no obvious signs but maintain lifelong viremia and are infectious to biting insects, which can then transmit the virus to other horses.
The inapparent carrier status is why Coggins testing matters: a horse that looks and acts completely healthy may be a chronic EIA carrier capable of infecting neighboring horses through insect vectors. Annual testing catches these horses before they remain in contact with others for years.
How the Coggins test works and what other tests exist
The Agar Gel Immunodiffusion (AGID) test, commonly called the Coggins test after Dr. Leroy Coggins who developed it in 1970, detects antibodies against EIA virus proteins in a horse's blood. A positive result means the horse has been exposed to EIA virus and is producing antibodies -- it is infected. There are no false positives from EIA vaccination (there is no vaccine), so a positive AGID is definitive.
ELISA (enzyme-linked immunosorbent assay) tests for EIA are also licensed. ELISA is faster and can screen large numbers of samples -- it is used for initial screening, with positive ELISA tests confirmed by AGID. A positive result on either test reported to state animal health officials triggers mandatory quarantine while the laboratory result is confirmed and officials determine the appropriate regulatory response.
Legal requirements and practical compliance
Federal law (9 CFR Part 75) requires a negative EIA test within 12 months for interstate transport of equids. Most states require testing for sale and for entry to fairgrounds, shows, trail rides, and boarding facilities. Some states require testing every 6 months for horses in high-risk activities or high-vector areas (wetlands, areas with heavy Tabanus fly populations). Check your state veterinarian's office for current requirements in your jurisdiction.
Practical compliance: annual Coggins testing is standard practice and typically costs $20-$50 depending on the laboratory and turnaround time. The current negative test certificate should accompany any horse traveling to competitions or shows. Keep digital copies accessible on your phone -- paper copies are required by some events but a photo backup prevents delay at gates when the original is misplaced.
Prevention
With no vaccine available, prevention is entirely through management. The EIA virus is not airborne -- it requires mechanical transmission (biting flies or blood-contaminated equipment). Preventive measures: use insect repellents, fans in stalls (reduce biting fly exposure), fine-mesh fly sheets and masks, strategic housing timing (biting flies are most active at dawn and dusk -- stabling during peak activity reduces exposure). Equipment hygiene is equally critical: never share needles between horses; use dedicated equipment for each horse at clinics and vet visits; ensure syringes and needles are single-use.
Sources: USDA APHIS EIA regulatory information (9 CFR Part 75); Coggins test development per Coggins L (1972) JAVMA; EIA pathophysiology per Merck Veterinary Manual; AAEP EIA guidelines; USDA EIA surveillance data 2020-2023.